Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
2.99
- 0.01 (-0.33%)
2:23 PM ET on Aug 30, 2016
Delayed at least 20 minutes.
Day High 3.03
Day Low 2.95
52-Week High 10.00
Volume 131,685
Print Friendly